Watson sends patent challenge notice to Ranbaxy
Sep 20, 2013, 05:12 PM ISTNew Delhi: Drug firm Ranbaxy Laboratories has said its US arm has received a notice from Watson Laboratories Inc, challenging the patent of acne treatment drug Absorica.The drug is licensed to Ranbaxy Laboratories from Cipher